324 related articles for article (PubMed ID: 8453633)
1. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
[TBL] [Abstract][Full Text] [Related]
2. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
[TBL] [Abstract][Full Text] [Related]
3. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
4. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
6. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells.
Marionnet C; Benoit A; Benhamou S; Sarasin A; Stary A
J Mol Biol; 1995 Oct; 252(5):550-62. PubMed ID: 7563073
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
[TBL] [Abstract][Full Text] [Related]
9. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients.
Dumaz N; Drougard C; Sarasin A; Daya-Grosjean L
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10529-33. PubMed ID: 8248141
[TBL] [Abstract][Full Text] [Related]
10. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations in human skin cancers.
Giglia-Mari G; Sarasin A
Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site.
Keijzer W; Mulder MP; Langeveld JC; Smit EM; Bos JL; Bootsma D; Hoeijmakers JH
Cancer Res; 1989 Mar; 49(5):1229-35. PubMed ID: 2645048
[TBL] [Abstract][Full Text] [Related]
14. Activated oncogenes in human tumors.
Suárez HG
Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
[TBL] [Abstract][Full Text] [Related]
15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
16. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
[TBL] [Abstract][Full Text] [Related]
17. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
[TBL] [Abstract][Full Text] [Related]
18. Far less frequent mutations in ras genes than in the p53 gene in skin tumors of xeroderma pigmentosum patients.
Sato M; Nishigori C; Lu Y; Zghal M; Yagi T; Takebe H
Mol Carcinog; 1994 Oct; 11(2):98-105. PubMed ID: 7916998
[TBL] [Abstract][Full Text] [Related]
19. DNA repair and its possible involvement in the origin of multiple cancer.
Takebe H; Tatsumi K; Satoh Y
Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():299-305. PubMed ID: 4009991
[TBL] [Abstract][Full Text] [Related]
20. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system.
Steingrimsdottir H; Beare D; Carr AM; Cole J; Lehmann AR
Oncogene; 1995 May; 10(10):2057-66. PubMed ID: 7761106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
